Patents
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
07/1996
07/11/1996WO1996020913A1 Novel trienoic retinoid compounds and methods
07/11/1996WO1996020710A1 Compounds for inhibition of ceramide-mediated signal transduction
07/11/1996WO1996020708A1 Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine
07/11/1996WO1996020703A1 Compounds for veterinary and medicinal applications
07/11/1996WO1996020702A1 The use of 2,3-alkylcarbonyloxybenzoic acid in treating adult respiratory distress syndrome
07/11/1996WO1996020690A2 3,3-(disubstituted)cyclohexan-1-ylidine acetate monomers and related compounds
07/11/1996WO1996020599A1 Pharmaceutical compositions for prevention and treatment of ulcerative colitis
07/11/1996CA2209134A1 Tricyclic retinoids, methods for their production and use
07/11/1996CA2208844A1 Acetylenes disubstituted with a 5 or 8 substituted tetrahydronaphthyl or dihydronaphthyl group and with an aryl or heteroaryl groups having retinoid-like biological activity
07/11/1996CA2208699A1 Anti-inflammatory cd14 polypeptides
07/11/1996CA2208679A1 Hydroxamic acid-containing inhibitors of matrix metalloproteases
07/11/1996CA2208580A1 Compounds for inhibition of ceramide-mediated signal transduction
07/11/1996CA2208016A1 Anti-inflammatory cd14 peptides
07/10/1996EP0720619A1 Selectin binding glycopeptides
07/10/1996EP0720609A1 3-(5-tetrazolyl-benzyl)amino-piperidine derivatives and antagonists of tachykinins
07/10/1996EP0720601A1 Gastrin and cck receptor ligands
07/10/1996EP0720600A1 3-(3,4-dioxyphenyl)-pyrrolidines as type iv phosphodiesterase inhibitors for the treatment of inflammatory diseases
07/10/1996EP0720598A1 Phenoxyphenyl cyclopentenyl hydroxyureas
07/10/1996EP0720484A1 Methods and products for controlling immune responses in mammals
07/10/1996EP0720481A1 Uses of vegetable oils
07/10/1996EP0720476A1 PHARMACEUTICAL COMPOSITION CONTAINING A DRUG/$g(b)-CYCLODEXTRIN COMPLEX IN COMBINATION WITH AN ACID-BASE COUPLE
07/10/1996EP0619818B1 Imidazoylalkyl substituted with a six membered nitrogen containing heterocyclic ring
07/10/1996CN1126435A Use of ropivacaine in the manufacture of a pharmaceutical with analgetic effect with minimal motor blockade
07/09/1996US5534539 Antitumor agents
07/09/1996US5534533 Carboxylate derivatives exhibiting phospholipase A2 inhibitory activity
07/09/1996US5534511 Aminoalkyl benzoxazolinones and benzothiazolinones
07/09/1996US5534509 Pharmaceutical composition regulating function of a living body
07/04/1996WO1996020281A1 Human phosphodiesterase type ivc, and its production and use
07/04/1996WO1996020217A1 Monoclonal antibody
07/04/1996WO1996020216A1 Fibronectin adhesion inhibitors
07/04/1996WO1996020215A2 Use of mhc-ii binding and/or mhc-ii mimicking molecules for the prevention and/or treatment of inflammatory diseases
07/04/1996WO1996020197A1 Spiroketal derivatives, compositions containing them and their use as therapeutic agents
07/04/1996WO1996020194A1 Novel quinuclidine derivatives and medicinal composition thereof
07/04/1996WO1996020193A1 Compounds and methods
07/04/1996WO1996020187A2 Esters and amides of non-steroidal anti-inflammatory carboxylic acids which may be used as anti-oxidants, 5-lipoxygenase inhibitors and non-steroidal anti-inflammatory products
07/04/1996WO1996020184A1 Naphthyl-benzoxazepines or -benzothiazepines as squalene synthetase inhibitors
07/04/1996WO1996020175A1 1,4,4-(trisubstituted)cyclohex-1-ene derivatives as pde iv- and tnf-inhibitors
07/04/1996WO1996020162A1 1,4,4-(trisubstituted)cyclohex-1-ene dimers and related compounds
07/04/1996WO1996020161A1 4,4-(disubstituted)cyclohexan-1-ol dimers and related compounds
07/04/1996WO1996020160A1 1,3,3-(trisubstituted)cyclohexane dimers and related compounds
07/04/1996WO1996020159A1 3,3-(disubstituted)cyclohexan-1-ylidine acetate monomers and related compounds
07/04/1996WO1996020157A1 3,3-(disubstituted)cyclohexan-1-ol dimers and related compounds
07/04/1996WO1996020156A1 3,3-(disubstituted)cyclohexan-1-carboxylate dimers and related compounds
07/04/1996WO1996020153A1 4,4-(disubstituted)cyclohexan-1-one dimers and related compounds
07/04/1996WO1996019993A1 1,3,3-(trisubstituted)cyclohex-1-ene monomers and related compounds
07/04/1996WO1996019991A1 Benzimidazoles as inhibitors of calcitriol metabolism
07/04/1996WO1996019988A1 4,4-(disubstituted)cyclohexan-1-ols monomers and related compounds
07/04/1996WO1996019985A1 3,3-(disubstituted)cyclohexan-1-ylidine acetate dimers and related compounds
07/04/1996WO1996019984A1 4,4-(disubstituted)cyclohexan-1-ylidine acetate dimers and related compounds
07/04/1996WO1996019983A1 4,4-(disubstituted)cyclohexan-1-ylidine acetate dimers and related compounds
07/04/1996WO1996019980A1 3,3-(disubstituted)cyclohexan-1-one dimers and related compounds
07/04/1996WO1996019979A1 1,4,4-(trisubstituted)cyclohexane dimers and related compounds
07/04/1996WO1996019978A1 1,3,3-(trisubstituted)cyclohex-1-ene dimers and related compounds
07/04/1996WO1996019977A1 3,3-(disubstituted)cyclohexan-1-ol monomers and related compounds
07/04/1996CA2208445A1 3,3-(disubstituted)cyclohexan-1-ol monomers and related compounds
07/04/1996CA2208444A1 4,4-(disubstituted)cyclohexan-1-ols monomers and related compounds
07/04/1996CA2208233A1 Use of mhc-ii binding and/or mhc-ii mimicking molecules for the prevention and/or treatment of inflammatory diseases
07/04/1996CA2207772A1 Naphthyl-benzoxazepines or -benzothiazepines as squalene synthetase inhibitors
07/04/1996CA2207653A1 Spiroketal derivatives, compositions containing them and their use as therapeutic agents
07/04/1996CA2204793A1 Fibronectin adhesion inhibitors
07/04/1996CA2182946A1 Human phosphodiesterase type ivc, and its production and use
07/03/1996EP0719787A1 Dicarboxymethylated glycolipid derivatives as cell adhesion inhibitors
07/03/1996EP0719770A1 Esculetin derivatives, method for manufacture thereof, and pharmaceutical composition
07/03/1996EP0719554A1 Chondroprotective flavonoids
07/03/1996EP0719549A1 Soft gelatine pharmaceutical dosage form containing a translucent gel
07/03/1996EP0719548A1 Gelling agent for polyethylene glycol
07/03/1996EP0719331A1 Eotaxin = eosinophil chemotactic cytokine
07/03/1996EP0719295A1 Polymeric matrices and their uses in pharmaceutical compositions
07/03/1996EP0719285A1 Il8 inhibitors
07/03/1996EP0719267A1 Second messenger cell signaling inhibitors
07/03/1996EP0719266A1 Heteroarylamino and heteroarylsulfonamido substituted 3-benzylaminomethyl piperidines and related compounds
07/03/1996EP0719253A1 3-amino-5-carboxy-substituted piperidines and 3-amino-4-carboxy-substituted pyrrolidines as tachykinin antagonists
07/03/1996EP0719156A1 Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agent and at least one of a decongestant, an expectorant, an antihistamine and an antitussive
07/03/1996EP0719155A1 $i(CAMPYLOBACTER JEJUNI) ANTIGENS, AND METHODS FOR THEIR PRODUCTION AND USE
07/03/1996EP0719145A1 Nitric oxide donor composition and method for treatment of anal disorders
07/03/1996CN1125946A Novel carbocyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines
07/03/1996CN1125944A Phenyl heterocycles as cyclooxygenase-2 inhibitors
07/03/1996CN1125941A Novel vitamin D analogues
07/03/1996CN1125938A Bicyclic amide derivatives and their use as muscle relaxants
07/03/1996CN1125600A "Hantongling"
07/03/1996CN1032207C Process for preparing imidazopyrazole derivatives, witch use as analgesics and anti-inflammatory agents
07/03/1996CN1032204C Process for preparing acetylenes disubstituted with phenyl group and heterobicyclic group having retinoid like activity
07/02/1996US5532383 Leukotriene B4 antagonists
07/02/1996US5532366 Enzyme inhibitors
07/02/1996US5532305 Hyaluronic acid and cationic polyacrylic acid copolymer for time release agents
07/02/1996US5532266 Treatment of hypoxia, antiedemic agents or antiinflammatory agents
07/02/1996US5532255 Anticoagulants, cardiovascular disorders, antiinflammatory agents, arteriosclerosis or antitumor agents
07/02/1996US5532248 O-aryl,O-alkyl, and O-alkenyl-macrolides having immunosuppressive activity
07/02/1996US5532237 Intraocular for treatment of glaucoma
07/02/1996US5532233 Platelet activating factor antagonist
07/02/1996US5532152 Platelet-activating factor acetylhydrolase
07/02/1996US5532150 Immobilized superoxide dismutase
07/02/1996US5531992 Antiinflammatory
07/02/1996US5530966 Protective garment for baseball umpires having an inner cushioned layer and an outer layer of interconnected plates
07/02/1996CA1338432C Esters of 3-demethylthiocolchicine and n-acyl analogs
06/1996
06/29/1996CA2166168A1 Esculetin derivatives, method for manufacture thereof, and pharmaceutical composition
06/27/1996WO1996019499A2 Improved cyclic crf antagonists
06/27/1996WO1996019469A1 Diaryl-2-(5h)-furanones as cox-2 inhibitors
06/27/1996WO1996019463A1 Heteroaromatic oxazole compounds and use thereof
06/27/1996WO1996019462A1 Oxazole derivatives and use thereof